ELAB Stock Analysis: Buy, Sell, or Hold?
ELAB - PMGC Holdings Inc. Common Stock
$14.00
8.01 (133.72%)
▲
5d:
+669.23%
30d:
+1286.14%
90d:
+845.95%
WAIT
LOW Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Mar 26, 2026
0d
Get Alerted When ELAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ELAB is 145.6% above fair value ($5.70). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ELAB is 145.6% above fair value ($5.70). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ELAB is currently trading at $14.00, which is considered extended relative to its 30-day fair value range of $0.42 to $5.70.
Technical Outlook: Technically, ELAB is in a downtrend. The price is approaching resistance at $8.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 133.7% recently.
Market Sentiment: ELAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELAB is in a downtrend. The price is approaching resistance at $8.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 133.7% recently.
Market Sentiment: ELAB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.42 -
$5.70
Company Quality Score
57/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.1%
All Signals
- BEARISH: Price significantly overextended (+145.6% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+133.7%)
- WARNING: Recommendation downgraded due to 145.6% overvaluation
Fair Price Analysis
30-Day Fair Range
$0.42 -
$5.70
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.62
Resistance Level
$8.10
Current Trend
Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Revenue Growth (YoY)
-45.8%
Share & Embed Analysis
Last updated: April 02, 2026 9:03 AM ET
Data refreshes hourly during market hours. Next update: 10:03 AM
Data refreshes hourly during market hours. Next update: 10:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELAB showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 63 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 65 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 62 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 52 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 59 HOLD |
